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Abstract
Background: Tanzania ranks 15th among the world’s 22 countries with the largest tuberculosis burden and
tuberculosis has continued to be among the major public health problems in the country. Limited data, especially
in patients co infected with HIV, are available to predict the duration of time required for a smear positive
pulmonary tuberculosis patient to achieve sputum conversion after starting effective treatment. In this study we
assessed the sputum smear and culture conversion rates among HIV positive and HIV negative smear positive
pulmonary tuberculosis patients in Dar es Salaam
Methods: The study was a prospective cohort study which lasted for nine months, from April to December 2008
Results: A total of 502 smear positive pulmonary tuberculosis patients were recruited. HIV test results were
obtained for 498 patients, of which 33.7% were HIV positive.
After two weeks of treatment the conversion rate by standard sputum microscopy was higher in HIV positive
(72.8%) than HIV negative(63.3%) patients by univariate analysis(P = 0.046), but not in multivariate analysis. Also
after two weeks of treatment the conversion rate by fluorescence microscopy was higher in HIV positive (72.8%)
than in HIV negative(63.2%) patients by univariate analysis (P = 0.043) but not in the multivariate analysis. The con-
version rates by both methods during the rest of the treatment period (8, 12, and 20 weeks) were not significantly
different between HIV positive and HIV negative patients.
With regards to culture, the conversion rate during the whole period of the treatment (2, 8, 12 and 20 weeks) were
not significantly different between HIV positive and HIV negative patients.
Conclusion: Conversion rates of standard smear microscopy, fluorescence microscopy and culture did not differ
between HIV positive and HIV negative pulmonary tuberculosis patients.
Background
The World Health Organization (WHO) estimates that
there are almost 13.7milion people living with tubercu-
losis and that the disease kills more young people and
adults than any other infectious disease in the world. A
total of about 1.77 million people died of tuberculosis in
2007 including 456,000 patients infected with human
immunodeficiency virus (HIV). Among the world’s 22
countries with the largest tuberculosis burden, Tanzania
ranks 15th [1] and tuberculosis has continued to be
among the major public health problems in the country
[2]. Tuberculosis control aims to reduce the spread of
the infection and the most efficient method for prevent-
ing transmission is identification and cure of infectious
pulmonary tuberculosis patients [3]. Monitoring tuber-
culosis patients during treatment is vital in order to
establish patients’ treatment outcomes and to measure
the national programme effectiveness [4]. Bacteriological
monitoring during treatment is needed in sputum smear
positive cases and, also, the microscopy results from
specimens collected at the end of treatment are used to
confirm the cure of the patients [2]. After conversion to
a negative smear the patient is unlikely to transmit
tuberculosis to contacts [2,5,6], therefore the conversion
rate may be used to determine the period whereby the
patient remains potentially infectious [6].
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Limited data, especially in patients co-infected with
HIV, are available to predict the duration of time
required for a smear positive pulmonary tuberculosis
patient to achieve sputum conversion after starting
effective treatment [7]. This study assessed the sputum
smear and culture conversion rates among HIV positive
and HIV negative smear positive pulmonary tuberculosis
patients in Dar es Salaam.
Methods
Study setting, design and population
The study was conducted in Dar es Salaam at Amana,
Temeke and Mwananyamala District Hospitals, and
Tandale, Magomeni and Mnazi Mmoja Health Centres.
The study was a prospective cohort study which lasted
for nine months, from April to December 2008. The
study subjects were patients attending the selected
health facilities, and who were diagnosed, by standard
smear microscopy, to have smear positive pulmonary
tuberculosis at baseline and who agreed to participate in
the study. Patients who did not stay in the study area
for the period of follow up and children below the age
of 15 years were not included in the study
Sample size
Allowing 10% drop out, the sample size required was
calculated to 500, assuming that the proportion who
were still smear positive after 2 months of treatment
was 12% and after 5 months 9%[8].
Data collection
Patient recruitment was done by the District Tuberculo-
sis and Leprosy Coordinators (DTLCs) of the respective
health facilities. Recruitment was continuous throughout
the study period. All new smear positive pulmonary
tuberculosis patients attending Mwananyamala, Amana
and Temeke District Hospitals, and Tandale, Magomeni
and Mnazi Mmoja health centres, were counseled about
the study. After obtaining informed consent, the patients
were interviewed and the information obtained, including
past history of anti-tuberculosis drugs for prophylactic
and/or treatment of active tuberculosis and demographic
characteristics such as age, sex, marital status, occupation
and level of education, was recorded in questionnaires.
After being interviewed the patients were asked to pro-
vide one sputum sample for smear microscopy and cul-
ture. The sputum collected, together with the two sputa
samples from the laboratory which were used for the
diagnosis, were sent to the Central Tuberculosis Refer-
ence Laboratory (CTRL) for repetition of standard smear
microscopy, fluorescence microscopy and culture using
Lowenstein-Jensen solid medium.
Patients were treated under Direct Observed Treat-
ment Short Course (DOTS) strategy. The patients were
given standard short course treatment of tuberculosis
regardless of their HIV status. HIV status of the subjects
was identified through the routine National Tuberculo-
sis and Leprosy Program (NTLP) screening of tubercu-
losis patients. We did not acquire information as to
whether the HIV positive patients were on Anti-Retro-
viral Therapy (ART) or not. Moreover, we did not
establish the levels of CD4+count of those patients who
were HIV positive or if there was any variation of the
level of CD4+counts with time during the follow-up
period
All the enrolled patients were seen again after two
weeks of treatment. At this visit, another sputum sample
was collected and sent to CTRL for culture, standard
smear microscopy and fluorescence microscopy to assess
conversion to a negative test. Patients who had a persis-
tent positive microscopy and/or culture were followed
up again at the 8th week with the same testing as by the
end of week 2.
Those who were still positive by microscopy and/or
culture were then followed up again at the 12th week,
and if they had not converted to negative bacteriology
they were followed up again at the 20th week, using the
same tests. At the CTRL there is an existing quality
control program which is under the NTLP
Statistical analysis
Completed questionnaires were double entered into a
computer software program (Epi Data version 3.1) fol-
lowed by data cleaning. The data was transferred to
SPSS version 15 for analysis. For categorical variables,
Pearson Chi-squares and Wald statistics were used, and
Student’s test was used for continuous variables. The
level of significance was set at p ≤ 0.05.
Smear microscopy results were used to estimate the
proportion of smear negative patients at 2, 8, 12 and 20
weeks. Culture results were used to estimate the propor-
tion of culture negative patients at 2, 8, 12 and
20 weeks. Logistic regression analysis was used to assess
and adjust for potential confounders associated with
sputum smear conversion. Candidate independent vari-
ables included sex, HIV status, age, past history of using
anti TB and education level. The procedure used was
backward elimination stepwise method that was based
on the probability of the likelihood-ratio statistic. Where
appropriate, adjusted odds ratios with 95% confidence
intervals are reported.
Ethical consideration
Ethical clearance was obtained from the Medical
Research Coordinating Committee of the Ministry of
Health and Social Welfare Tanzania (MoHSW). Permis-
sion to conduct the study was sought from the respec-
tive authorities where the study was conducted.
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The goal and benefits of the study were explained to the
study participants and oral informed consents were
obtained from the participants prior to enrolment.
Results
A total of 502 smear positive pulmonary tuberculosis
patients were recruited. HIV test results were obtained
for 498 patients, of which 33.7% were HIV positive. The
proportion of males in those who were HIV positive
was 64.9% and 71.5% in those who were HIV negative.
The mean age was 35.7 ± 9.5 years for HIV positive and
30.1 ± 10.2 years for HIV negative patients. Among HIV
positive tuberculosis patients there were more patients
within the age group >35 years (47%) as compared to
HIV negative tuberculosis patients (22.4%) (X2 = 31.652,
d.f. = 1, P = 0.001). With regards to marital status, there
were significantly less single (Wald statistic = 12.283, P
= 0.01) and cohabiting (Wald statistic = 3.879, P =
0.049), and more married (Wald statistic = 6.320, P =
0.012) individuals between tuberculosis patients who
were HIV positive compared to those who were HIV
negative. (Table 1)
The proportion of patients with past history of using
anti-tuberculosis drugs was significantly higher in HIV
positive (23.2%) as compared to HIV negative tuberculo-
sis patients (10.9%) (X2= 13.177, d.f. = 1, P = 0.001).
(Table 2)
With regards to standard sputum microscopy, after
two weeks of treatment the conversion rate was higher
in HIV positive (72.8%) than HIV negative(63.3%)
patients by univariate analysis, and the difference was
statistically significant (X2= 3.99, d.f = 1, P = 0.046).
However, when we entered the data in the logistic
model and did a backward elimination using stepwise
method, variables remaining in the model were sex and
HIV status. Males were less likely to convert to a nega-
tive test (OR = 0.49; 95%C I 0.31-0.78), and HIV posi-
tive were more likely to convert to a negative test,
although HIV status did not reach statistical significance
(OR = 1.50; 95% CI 0.97 - 2.31). The conversion rates
by standard smear microscopy during the rest of the
treatment period (8, 12 and 20 weeks) were not signifi-
cantly different between HIV positive and HIV negative
patients. (Table 3 &4)
After two weeks of treatment the conversion rate by
fluorescence microscopy was higher in HIV positive
(72.8%) than in HIV negative (63.2%) patients by univari-
ate analysis and this difference was also statistically sig-
nificant (X2= 4.08, d.f = 1, P = 0.043). However, when we
entered the data in the logistic model and did a backward
elimination using stepwise method, variables remaining
in the model were sex and HIV status. Males were less
likely to convert to a negative test (OR = 0.49; 95% CI
0.31-0.78), and HIV positive were more likely no convert
to a negative test, although HIV status did not reach sta-
tistical significance (OR = 1.50; 95% CI 0.97 - 2.31). The
conversion rates by fluorescence microscopy during the
rest of the treatment period (8, 12, and 20 weeks) were
not significantly different between HIV positive and HIV
negative patients. (Table 3 &4)
With regards to culture, the conversion rate during
the whole period of the treatment (2, 8, 12 and 20
weeks) were not significantly different between HIV
positive and HIV negative patients. (Table 3)
Table 1 General characteristics of smear positive
pulmonary tuberculosis patients in Dar es Salaam
Characteristic HIV Positive
N = 168
% (n)
HIV Negative
N = 330
% (n)
p-
value
HIV result s 33.7 (168) 66.3 (330)
Sex
Male 64.9 (109) 71.5 (236) 0.13
Female 35.1 (59) 28.5 (94)
Mean ± SD age in
years
35.7 ± 9.5 30.1 ± 10.2 0.001
Age groups(years)
15-35 53.0 (89) 77.6 (256) <0.001
>35 47.0 (79) 22.4 (74)
Age group(years)
15-25 11.9(20) 37.6 (124) <0.001
26-35 41.1 (69) 40.0 (132)
36-45 33.3 (56) 15.5 (51)
>45 13.7 (23) 7.0(23)
Education
No education 25.0 (42) 24.2 (80) 0.85
Have education 75.0 (126) 75.8 (250)
Education level
No formal education 8.9(15) 7.6(26) 0.92
Primary education 76.2 (128) 76.7 (253)
Secondary education
and above
14.9 (25) 15.5 (51)
Occupation
Unemployed 27.4 (46) 27.0 (89) 0.79
Employed 15.5 (26) 17.9 (59)
Self employed 57.1 (96) 55.2 (182)
Marital status
Single 33.3 (56) 51.5 (170) 0.01
Married 41.1 (69) 38.8 (128) 0.012
Cohabiting 3.0(5) 3.3(11) 0.049
Separate/Divorce 14.9 (25) 4.2(14) 0.95
Widowed 7.7(13) 2.1(7) 0.19
BCG scar
Present 64.3 (108) 70.3 (232) 0.17
Absent 35.7 (60) 29.7 (98)
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Discussion
The study revealed that the conversion rates as judged
by standard smear microscopy and fluorescence micro-
scopy after two weeks of treatment was higher in HIV
positive pulmonary tuberculosis patients than in those
who were HIV negative. However, this applies only to
the univariate analysis. After doing a multivariable ana-
lysis, the HIV status did not come out as significant
anymore. These results are in line with reviews done in
past studies, which have indicated that HIV serostatus
does not influence sputum smear conversion rate [7,9].
However a study which was done in Karonga district in
Malawi showed that the presence of HIV infection was
associated with a shorter time to sputum smear conver-
sion [6].
In our study, the conversion rate of culture was not
different between HIV positive and HIV negative pul-
monary tuberculosis patients. Previous findings such as
the one in a study which was done in New Jersey have
also shown that HIV serostatus did not influence the
rate of documented sputum culture conversion [10].
However our results differ from a study which was done
in Spain where it was found that HIV infected patients
had a significantly higher culture conversion rate by
week 4 than HIV negative patients in the univariate ana-
lysis. But, in this same Spanish study after a multivariate
analysis, the HIV status did not emerge as being signifi-
cantly associated with culture conversion during the
early period [11].
Currently the duration of infectiousness after the
initiation of effective treatment is still a subject of
Table 2 Symptoms and disease past history of smear
positive pulmonary tuberculosis patients
Characteristic HIV Positive
N = 168
% (n)
HIV Negative
N = 330
% (n)
p-value
Cough
Yes 98.2 (165) 98.5 (325) 0.82
No 1.8(3) 1.5(5)
Chest pain
Yes 69.6 (117) 72.7 (240) 0.47
No 30.4 (51) 27.3 (90)
Fever
Yes 73.8 (124) 68.2(225) 0.20
No 26.2 (44) 31.8(105)
Night sweats
Yes 61.9 (104) 68.2 (225) 0.16
No 38.1 (64) 31.8 (105)
Loss of weight
Yes 88.1 (148) 85.8 (283) 0.47
No 11.9 (20) 14.2 (47)
Past history of TB
Yes 13.7 (23) 8.5(28) 0.07
No 86.3 (145) 91.5 (302)
Past history of anti-TB
Yes 23.2 (39) 10.9 (36) < 0.001
No 76.8 (129) 89.1 (294)
Family member with TB
Yes 16.1 (27) 18.2 (60) 0.56
No 83.9 (141) 81.8 (270)
Table 3 Proportions of negative cases (conversion rates) after different durations of treatment according to HIV status
Type of test Duration of treatment (weeks) HIV positive % (n/N) HIV negative % (n/N) P value
Zeihl Neelsen smear
2 72.8(107/147) 63.3(197/311) 0.0457
8 98.6(139/141) 97.0(295/304) 0.52
12 99.3(140/141) 98.0(298/304) 0.56
20 99.3(140/141) 99.0(301/304) 0.80
Fluorescence 2 72.8(107/147) 63.2(196/310) 0.0433
8 98.6(139/141) 97.0(294/303) 0.51
12 99.3(140/141) 98.0(297/303) 0.55
20 99.3(140/141) 99.0(300/303) 0.80
Culture 2 59.4(85/143) 51.8(156/301) 0.13
8 95.7(134/140) 92.5(272/294) 0.21
12 98.6(137/139) 97.3(285/293) 0.62
20 100(138/138) 98.6(289/293) 0.40
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discussion. From our results it is shown that after two
weeks of treatment about 30% to 40% of the patients
were still potentially infectious, depending on HIV sta-
tus. This is in contrary to the belief that patients
become non-infectious after two weeks of standard
treatment regimen. This finding is in line with other
results which have also shown that conversion to a
negative test and hence the loss of infectiousness of pul-
monary tuberculosis patients during therapy does not
occur rapidly in all patients [6,11,12]. This finding has
implications to those countries which practise patients’
isolation during the infectious period and are using two
weeks as a time which usually a patient is considered to
become non-infectious. For example in the UK, the
National Institute of Clinical Excellence (NICE) guide-
lines indicate that the isolation of smear-positive tuber-
culosis patients without risk factors for Multi-Drugs
Resistant tuberculosis is generally only required for
2 weeks [13].
The results of standard smear and fluorescence micro-
scopy were almost identical and we are inclined to rea-
son that this might have occurred because there was no
blinding between the two tests. But it may also reflect
that the quality of microscopy in general was very high
in that particular laboratory (CT RL). The HIV sero-
prevalence of 33.7% found in our study population is
almost twice that of blood donors in the study region
(17.4% in 2005) [14]. But this is low compared to the
HIV prevalence which has been estimated by the
MoHSW which sets the HIV prevalence to about 50%
of all tuberculosis patients in Tanzania [2,15]. The rea-
son why the HIV sero-prevalence that we found is low
compared to that of the MoHSW might be that we only
included smear positive pulmonary tuberculosis. Since
most of the HIV positive pulmonary tuberculosis
patients are smear negative, it is possible that our study
inclusion criteria might have excluded many HIV posi-
tive/smear negative pulmonary tuberculosis patients.
These HIV positive/smear negative patients are included
in the MoHSW prevalence estimates.
Pulmonary tuberculosis patients who were also HIV
positive were older compared to those who were HIV
negative. Most of those who were HIV positive were in
the age group 26-35 years. These results are consistent
with the data from Tanzania National AIDS Control
Programme of 2005 which shows that the age group 20-
49 years remained the most affected by HIV for both
sexes, an observation that has remained consistent for
several years since the beginning of the epidemic [14].
The proportion of patients with past history of using
anti-tuberculosis drugs was higher in HIV positive than
in HIV negative pulmonary tuberculosis patients. This
may be due to the fact that tuberculosis preventive ther-
apy is an intervention that has been part of the package
of care for people living with HIV. In this tuberculosis
preventive therapy, patients with latent infection of
M. tuberculosis are given Isoniazid in order to prevent
progression to active disease [15].
Conclusion
Conversion rate of standard smear microscopy and
fluorescence microscopy did not differ between HIV
positive and HIV negative pulmonary tuberculosis
patients. Also the conversion rates of culture were not
different between HIV positive and HIV negative pul-
monary tuberculosis patients.
After two weeks of treatment 30% to 40% of the pul-
monary tuberculosis patients were still potentially infec-
tious, depending on HIV status. The age of those who
were HIV positive was higher compared to those who
were HIV negative. Being HIV positive was associated
with a past history using anti-tuberculosis drugs.
Acknowledgements
We thank the patients for consenting to participate in the study, the TB
districts coordinators and nurses for enrolling patients and laboratory
technicians for performing smear and culture analyses. We thank the
National Institute for medical Research for granting study approval. The
study was funded by Norwegian government through the State Educational
Loan Fund.
Author details
1National Institute for Medical Research, Muhimbili Medical Research Centre,
Dar es Salaam, Tanzania. 2Centre for International Health, University of
Bergen, Bergen, Norway.
Authors’ contributions
All authors contributed to the paper, all authors conceived the study. MS
conducted the study. SGM, and OM supervised the research. MS and SGM
analysed the data. All authors helped to conceptualise ideas and interpret
the findings. MS prepared the draft, other authors helped to review and
finalise the manuscript
Competing interests
The authors declare that they have no competing interests.
Received: 8 February 2010 Accepted: 16 July 2010
Published: 16 July 2010
References
1. Global tuberculosis control; epidermiology, strategy, financing: WHO
report. Geneva: World Health Organization 2009.
Table 4 Logistic regression analysis of factors* associated
with sputum smear** conversion at two weeks of
treatment
Variable OR (95% CI) P value
Males 0.49 (0.31 - 0.78) 0.002
HIV positive 1.50 (0.97 - 2.31) 0.07
*factors adjusted for were sex, HIV status, age, past history of using anti-TB
and education level regardless of their P value
**Ziehl Neelsen and auramine staining gave identical results
OR = odds ratio
CI = Confidence Interval
Senkoro et al. BMC Infectious Diseases 2010, 10:210
http://www.biomedcentral.com/1471-2334/10/210
Page 5 of 6
2. Manual of the National Tuberculosis and Leprosy Programme in
Tanzania. The United Republic of Tanzania, Fifth 2006.
3. Feng-zeng Z, Levy MH, Su min W: Sputum microscopy results at two and
three months predict outcome of tuberculosis treatment. Int J Tuberc
Lung Dis 1997, 1(6):570-572.
4. Kumaresan JA, Ahsan Ali AK, Parkkali LM: Tuberculosis control in
Bangladesh: success of the DOTS strategy. Int J Tuberc Lung Dis 1998,
2(12):992-998.
5. Dawson D, Kim SJ: Quality Assuarance of Sputum Microscopy in DOTS
Programmes: Regional Guide lines for Countries in the Western Pacific.
Philippines: World Health OrganizationTuberculosis S 2003.
6. Dominguez-Castellano A, Muniain MA, Rodriguez-Bano J, Garcia M, Rios MJ,
Galvez J, Perez-Cano R: Factors associated with time to sputum smear
conversion in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2003,
7(5):432-438.
7. Telzak EE, Fazal BA, Pollard CL, Turett GS, Justman JE, Blum S: Factors
Influencing Time to Sputum Conversion Among Patients with Smear-
Positive Pulmonary Tuberculosis. Clinical Infectious Disiease 1997,
25:666-670.
8. Rutta E, Kipingili R, Lukonge H, Assefa S, Mitsilale E, Rwechungura S:
Treatment outcome among Rwandan and Burundian refugees with
sputum smear-positive tuberculosis in Ngara, Tanzania. Int J Tuberc Lung
Dis 2001, 5(7):628-632.
9. Glynn JR, Warndorff DK, Fine PEM, Munthali MM, Sichome W,
Ponnighans JM: Measurement and determinants of tuberculosis outcome
in Karonga District, Malawi. Bulletin of the World Health Organization 1998,
76(3):295-305.
10. Liu Z, Shilkret K, Ellis H: Predictors of sputum culture conversion among
patients with tuberculosis in era of tuberculosis resurgence. Arch Intern
Med 1999, 159(10):1110-1116.
11. Fortun J, Martin-Divila P, Molina A, Navas E, Hermida JM, Cobo J, Gomez-
Mampaso E, Moreno S: Sputum conversion among patients with
pulmonary tuberculosis: are there implications for removal of respiratory
isolation. Jornal of Antimicrobial Chemotherapy 2007, 59:794-798.
12. Guler M, Unsal E, Dursun B, Aydln O, Capan N: Factors influencing sputum
smear and culture conversion time among patients with new case
pulmonary tuberculosis. International Jornal of Clinical Practice 2007,
61(2):231-235.
13. Tuberculosis: Clinical diagnosis and management of tuberculosis, and
measures for its prevention and control. Exelence NIfHaC: The National
Collaborating Centre for Chronic Conditions 2006.
14. HIV/AIDS/STI Surveillance Report. Programme NAC:The United Republic
of Tanzania 2005.
15. National Guidelines for the Management of HIV and AIDS. Programme
NAC, The United Republic of Tanzania, Ministry of Health and Social
Welfare, Third 2008.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/10/210/prepub
doi:10.1186/1471-2334-10-210
Cite this article as: Senkoro et al.: Smear microscopy and culture
conversion rates among smear positive pulmonary tuberculosis patients
by HIV status in Dar es Salaam, Tanzania. BMC Infectious Diseases 2010
10:210.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Senkoro et al. BMC Infectious Diseases 2010, 10:210
http://www.biomedcentral.com/1471-2334/10/210
Page 6 of 6
